Nasolabial Fold Wrinkles Clinical Trial
Official title:
A Controlled, Randomized, Double-Blinded, Intra-Subject, Multicenter, Prospective, Clinical Study to Investigate the Non-Inferiority Between the Polymeric Microspheres and Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds
This is a single-dose, randomized, double-blind, active-controlled, split-face, multiple centers, non-inferiority study. Approximately 50 nasolabial fold subjects will be enrolled. Each enrolled subject will be randomized equally into one of the following groups: 1. Group 1: right face will be injected with PBF PLLA microsphere, and left face with Sculptra® 2. Group 2: right face will be injected with Sculptra® and left face with PBF PLLA microsphere Subjects will be administrated on Visit 1 by applying PBF PLLA microsphere on one side of face and Sculptra® on the other.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00444210 -
DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles
|
Phase 3 | |
Not yet recruiting |
NCT05162326 -
BC-101 in Treatment of Nasolabial Fold Wrinkles
|
Phase 1 | |
Completed |
NCT00444353 -
DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up
|
Phase 3 |